Verily, the life sciences business under Alphabet, said Friday that it has raised $1 billion, capital that will be used to expand its data-driven healthcare products tailored to individuals.
The round was led by Alphabet, the company said in its announcement.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,